Renoprotective effects of asialoerythropoietin in diabetic mice against ischaemia-reperfusion-induced acute kidney injury: Original Article

Nephrology

Volumn 15, Issue 1, 2010, Pages 93-101

  Nakazawa, Jun ^a   Isshiki, Keiji ^a   Sugimoto, Toshiro ^a   Araki, Shin Ichi ^a   Kume, Shinji ^a   Yokomaku, Yukiyo ^a   Chin Kanasaki, Masami ^a   Sakaguchi, Masayoshi ^a   Koya, Daisuke ^b   Haneda, Masakazu ^c   Kashiwagi, Atsunori ^a   Uzu, Takashi ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^b KANAZAWA MEDICAL UNIVERSITY   (Japan)

^c ASAHIKAWA MEDICAL COLLEGE   (Japan)

Author keywords

Acute tubular necrosis; Apoptosis; Bone morphogenetic protein; Erythropoietin; Fibrosis; Ischaemia reperfusion

Indexed keywords

ASIALOERYTHROPOIETIN; ERYTHROPOIETIN; OSTEOGENIC PROTEIN 1; PROTEIN BCL 2; STREPTOZOCIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; C57BL 6 MOUSE; CELL PROLIFERATION; CONTROLLED STUDY; INTERSTITIAL NEPHRITIS; KIDNEY INJURY; KIDNEY ISCHEMIA; KIDNEY TUBULE CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RENAL PROTECTION; REPERFUSION; STREPTOZOCIN DIABETES;

ANIMALS; ASIALOGLYCOPROTEINS; DIABETES MELLITUS, EXPERIMENTAL; ERYTHROPOIETIN; KIDNEY FAILURE, ACUTE; MALE; MICE; MICE, INBRED C57BL; REPERFUSION INJURY;

EID: 77149125907     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/j.1440-1797.2009.01170.x     Document Type: Article

References (27)

1. Bagshaw SM. Short- and long-term survival after acute kidney injury. Nephrol. Dial. Transplant. 2008 23 : 2126 2128.
2. Weisberg LS, Kurnik PB, Kurnik BR. Risk of radiocontrast nephropathy in patients with and without diabetes mellitus. Kidney Int. 1994 45 : 259 265.
3. Grenfell A. Acute renal failure in diabetics. Intensive Care Med. 1986 12 : 6 12.
4. Ishani A, Xue JL, Himmelfarb J et al. Acute kidney injury increases risk of ESRD among elderly. J. Am. Soc. Nephrol. 2009 20 : 223 228.
5. Melin J, Hellberg O, Akyurek LM, Kallskog O, Larsson E, Fellstrom BC. Ischemia causes rapidly progressive nephropathy in the diabetic rat. Kidney Int. 1997 52 : 985 991.
6. Humphries JE. Anemia of renal failure. Use of erythropoietin. Med. Clin. North Am. 1992 76 : 711 725.
7. Westenfelder C, Biddle DL, Baranowski RL. Human, rat, and mouse kidney cells express functional erythropoietin receptors. Kidney Int. 1999 55 : 808 820.
8. Ribatti D, Vacca A, Roccaro AM, Crivellato E, Presta M. Erythropoietin as an angiogenic factor. Eur. J. Clin. Invest. 2003 33 : 891 896.
9. Bogoyevitch MA. An update on the cardiac effects of erythropoietin cardioprotection by erythropoietin and the lessons learnt from studies in neuroprotection. Cardiovasc. Res. 2004 63 : 208 216.
10. Wang W, Zhang J. Protective effect of erythropoietin against aristolochic acid-induced apoptosis in renal tubular epithelial cells. Eur. J. Pharmacol. 2008 588 : 135 140.
11. Srisawat N, Manotham K, Eiam-Ong S, Katavetin P, Praditpornsilpa K, Eiam-Ong S. Erythropoietin and its non-erythropoietic derivative: Do they ameliorate renal tubulointerstitial injury in ureteral obstruction? Int. J. Urol. 2008 15 : 1011 1017.
12. Rossert J, Eckardt KU. Erythropoietin receptors: Their role beyond erythropoiesis. Nephrol. Dial. Transplant. 2005 20 : 1025 1028.
13. Yokomaku Y, Sugimoto T, Kume S et al. Asialoerythropoietin prevents contrast-induced nephropathy. J. Am. Soc. Nephrol. 2008 19 : 321 328.
14. Sharples EJ, Yaqoob MM. Erythropoietin in experimental acute renal failure. Nephron Exp. Nephrol. 2006 104 : e83 8.
15. Chien CT, Lee PH, Chen CF, Ma MC, Lai MK, Hsu SM. De novo demonstration and co-localization of free-radical production and apoptosis formation in rat kidney subjected to ischemia/reperfusion. J. Am. Soc. Nephrol. 2001 12 : 973 982.
16. Gobe G, Zhang XJ, Cuttle L et al. Bcl-2 genes and growth factors in the pathology of ischaemic acute renal failure. Immunol. Cell Biol. 1999 77 : 279 286.
17. Kumar D, Zimpelmann J, Robertson S, Burns KD. Tubular and interstitial cell apoptosis in the streptozotocin-diabetic rat kidney. Nephron Exp. Nephrol. 2004 96 : e77 88.
18. Vukicevic S, Basic V, Rogic D et al. Osteogenic protein-1 (bone morphogenetic protein-7) reduces severity of injury after ischemic acute renal failure in rat. J. Clin. Invest. 1998 102 : 202 214.
19. Sugimoto H, Grahovac G, Zeisberg M, Kalluri R. Renal fibrosis and glomerulosclerosis in a new mouse model of diabetic nephropathy and its regression by bone morphogenic protein-7 and advanced glycation end product inhibitors. Diabetes 2007 56 : 1825 1833.
20. Zeisberg M, Shah AA, Kalluri R. Bone morphogenic protein-7 induces mesenchymal to epithelial transition in adult renal fibroblasts and facilitates regeneration of injured kidney. J. Biol. Chem. 2005 280 : 8094 8100.
21. Zeisberg M. Bone morphogenic protein-7 and the kidney: Current concepts and open questions. Nephrol. Dial. Transplant. 2006 21 : 568 573.
22. Wang SN, Lapage J, Hirschberg R. Loss of tubular bone morphogenetic protein-7 in diabetic nephropathy. J. Am. Soc. Nephrol. 2001 12 : 2392 2399.
23. Mitu GM, Wang S, Hirschberg R. BMP7 is a podocyte survival factor and rescues podocytes from diabetic injury. Am. J. Physiol. Renal Physiol. 2007 293 : F1641 8.
24. Ding H, Kopple JD, Cohen A, Hirschberg R. Recombinant human insulin-like growth factor-I accelerates recovery and reduces catabolism in rats with ischemic acute renal failure. J. Clin. Invest. 1993 91 : 2281 2287.
25. Nitescu N, Ricksten SE, Marcussen N et al. N-acetylcysteine attenuates kidney injury in rats subjected to renal ischaemia-reperfusion. Nephrol. Dial. Transplant. 2006 21 : 1240 1247.
26. Hirschberg R, Kopple J, Lipsett P et al. Multicenter clinical trial of recombinant human insulin-like growth factor I in patients with acute renal failure. Kidney Int. 1999 55 : 2423 2432.
27. Ho KM, Morgan DJ. Meta-analysis of N-Acetylcysteine to prevent acute renal failure after major surgery. Am. J. Kidney Dis. 2009 53 : 33 40.